April 20, 2009
Last week, the New York Times carried an article "FDA Rules on Ads Sow Confusion as Applied to the Web" that addresses the call by the agency to issue 14 letters regarding 45 brands based on the lack of risk … Continue reading →
April 16, 2009
Yesterday I had the good fortune to participate on a panel staged at the National DTC Perspectives Conference held here in Washington. The conference was impressive not only because of the size and scope of the turnout – hundreds … Continue reading →
April 15, 2009
This week it was announced that a senior fellow from the office of Senator Edward Kennedy would be heading back to FDA as a senior counselor to Dr. Joshua Sharfstein where it is reported that the FDA Office of Legislative … Continue reading →
April 13, 2009
The issuance of the 14 untitled letters by the FDA a week ago Friday has been very troubling on a number of circumstances. The agency accompanied the action that the letters were sent as part of "routine monitoring" which, unfortunately, … Continue reading →
April 10, 2009
The cherry blossoms are done, but for some reason, the tourists are still sticking around Washington. The Administration continues to fill jobs, though frankly not at a fast enough rate, with the Secretary of HHS still unconfirmed as is the … Continue reading →